Европейски съюз - датски - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - olivenolie, soyaolie - infusionsvæske, emulsion - 200 mg/ml

Европейски съюз - датски - EMA (European Medicines Agency)

intervet international bv - levende deletion-mutant streptococcus equi stamme tw928 - immunologier til hovdyr - heste - for vaccination af heste mod streptococcus equi at reducere kliniske symptomer og forekomst af lymfeknuder-node bylder. immunitetens begyndelse: påbegyndelsen af ​​immunitet er etableret som to uger efter basisvaccination. varighed af immunitet: varigheden af ​​immunitet er op til tre måneder. vaccinen er beregnet til anvendelse i heste, hvor der er tydeligt identificeret en risiko for streptococcus equi-infektion på grund af kontakt med heste fra områder, hvor dette patogen er kendt for at være til stede, e. stalde med heste, der rejser til shows eller konkurrencer i sådanne områder, eller stalde, der henter eller har livery heste fra sådanne områder.

Европейски съюз - датски - EMA (European Medicines Agency)

merial - levende svækkede muscovy duck parvovirus - immunologicals for aves, duck parvovirus, live viral vacciner - Ænder - aktiv immunisering af ænder for at forhindre dødelighed1 og for at reducere vægttab og læsioner af and-parvovirose og derzsy's sygdom. 1i mangel på maternelt afledte antistoffer.

Европейски съюз - датски - EMA (European Medicines Agency)

dompé biotec s.p.a. - darbepoetin alfa - kidney failure, chronic; anemia; cancer - antianemiske præparater - behandling af symptomatisk anæmi forbundet med kronisk nyresvigt (crf) hos voksne og pædiatriske patienter. behandling af symptomatisk anæmi hos voksne patienter med cancer i ikke-myeloide maligniteter, der modtager kemoterapi.

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - alanin, arginin, asparaginsyre, calciumchloriddihydrat, cystein, glucosemonohydrat, glutaminsyre, glycin, histidin, isoleucin, kaliumacetat, leucin, lysinmonohydrat, magnesiumacetattetrahydrat, methionin, natriumchlorid, natriumglycerophosphat, hydreret, olivenolie, renset, ornithinmonohydrochlorid, phenylalanin, prolin, serin, soyaolie, renset, taurin, threonin, tryptophan, tyrosin, valin - infusionsvæske, emulsion

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - alanin, arginin, asparaginsyre, calciumchloriddihydrat, cystein, glucosemonohydrat, glutaminsyre, glycin, histidin, isoleucin, kaliumacetat, leucin, lysinmonohydrat, magnesiumacetattetrahydrat, methionin, natriumchlorid, natriumglycerophosphat, hydreret, olivenolie, renset, ornithinmonohydrochlorid, phenylalanin, prolin, serin, soyaolie, renset, taurin, threonin, tryptophan, tyrosin, valin - infusionsvæske, emulsion

Европейски съюз - датски - EMA (European Medicines Agency)

laboratoires smb s.a. - fenofibrat, pravastatin - dyslipidæmi - lipid modificerende midler - pravafenix er indiceret til behandling af høj-koronar--hjertesygdom (chd)-risikerer voksne patienter med blandet dyslipidaemia kendetegnet ved høje triglycerider og lav hdl-cholesterol (c) niveauer hvis ldl-c niveauer er tilstrækkeligt kontrolleret under på en behandling med pravastatin-40-mg monoterapi.

Европейски съюз - датски - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiske stoffer til suidae - svin (slagtekyllinger) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Европейски съюз - датски - EMA (European Medicines Agency)

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.